JM Benítez Cantero

Dose escalation or swap for loss of response to biological therapy in IBD?

Abstract Biological therapies have transformed the management of inflammatory bowel disease (IBD). Nevertheless, a substantial proportion of patients experience primary non-response or secondary loss of response during treatment. This phenomenon represents a major therapeutic challenge and often requires treatment opt...